CAS 2098902-68-0
:KDM4D-IN-1
Description:
KDM4D-IN-1, identified by its CAS number 2098902-68-0, is a small molecule inhibitor specifically targeting the lysine demethylase KDM4D, which is involved in the regulation of gene expression through histone modification. This compound is characterized by its ability to selectively inhibit the enzymatic activity of KDM4D, thereby influencing epigenetic processes and potentially impacting cancer cell proliferation and survival. KDM4D-IN-1 is typically studied in the context of cancer research, particularly for its potential therapeutic applications in tumors where KDM4D is overexpressed. The compound's structure includes specific functional groups that facilitate its binding to the active site of the enzyme, enhancing its inhibitory efficacy. Additionally, KDM4D-IN-1 is often evaluated for its pharmacokinetic properties, including solubility, stability, and bioavailability, which are crucial for its development as a therapeutic agent. Overall, KDM4D-IN-1 represents a promising avenue for targeted cancer therapy through epigenetic modulation.
Formula:C11H7N5O
Synonyms:- KDM4D-IN-1, >98%
- KDM4D inhibitor 1
- KDM4D-IN-1
- Pyrazolo[1,5-a]pyrido[3,2-e]pyrimidine-3-carbonitrile, 4,5-dihydro-2-methyl-5-oxo-
- KDM4D-IN-10r
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
KDM4D-IN-1
CAS:<p>KDM4D-IN-1 is a KDM4D inhibitor (IC50: 0.41±0.03 μM).</p>Formula:C11H7N5OPurity:99.51% - >99.99%Color and Shape:SolidMolecular weight:225.21KDM4D-IN-1
CAS:<p>KDM4D-IN-1 is a chemical compound that acts as a selective inhibitor. It is derived synthetically to target the KDM4D enzyme, a member of the Jumonji family of histone demethylases. The mode of action involves the inhibition of the catalytic activity of KDM4D, which regulates the demethylation of lysine residues on histones, specifically demethylating H3K9me3/me2. This regulation plays a significant role in chromatin remodeling and gene expression.</p>Formula:C11H7N5OPurity:Min. 95%Molecular weight:225.21 g/mol
